Data obtained in vitro with cardiomyocytes infected by T. cruzi and treated with anti-TGF-β compounds were confirmed in vivo, with an experimental model of acute phase infection [17–19], in which we observed reduced parasitemia followed by reduced cardiac damage and extracellular matrix deposition [18,19]. Here, TGFB1 is linked to infection.